Portfolio Analysis of Research Grants in Data Science Funded by the National Heart, Lung, and Blood Institute.


Journal

Circulation. Genomic and precision medicine
ISSN: 2574-8300
Titre abrégé: Circ Genom Precis Med
Pays: United States
ID NLM: 101714113

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 23 11 2019
medline: 28 8 2020
entrez: 23 11 2019
Statut: ppublish

Résumé

Leveraging emerging opportunities in data science to open new frontiers in heart, lung, blood, and sleep research is one of the major strategic objectives of the National Heart, Lung, and Blood Institute (NHLBI), one of the 27 Institutes/Centers within the National Institutes of Health (NIH). To assess NHLBI's recent funding of research grants in data science and to identify its relative areas of focus within data science, a portfolio analysis from fiscal year 2008 to fiscal year 2017 was performed. In this portfolio analysis, an efficient and reliable methodology was used to identify data science research grants by utilizing several NIH databases and search technologies (iSearch, Query View Reporting system, and IN-SPIRE [Pacific Northwest National Laboratory, Richland, WA]). Six hundred thirty data science-focused extramural research grants supported by NHLBI were identified using keyword searches based primarily on NIH's working definitions of bioinformatics and computational biology. Further analysis characterized the distribution of these grants among the heart, lung, blood, and sleep disease areas as well as the subtypes of data science projects funded by NHLBI. Information was also collected for data science research grants funded by other NIH institutes/centers using the same search and analysis methodology. The funding comparison among different NIH institutes/centers highlighted relative data science areas of emphasis and further identified opportunities for potential data science areas in which NHLBI could foster research advances.

Identifiants

pubmed: 31752505
doi: 10.1161/CIRCGEN.119.002746
pmc: PMC7032595
mid: NIHMS1548972
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e002746

Subventions

Organisme : Intramural NIH HHS
ID : Z99 HL999999
Pays : United States

Références

PLoS Biol. 2015 Jul 07;13(7):e1002195
pubmed: 26151137
JAMA. 2018 Sep 18;320(11):1103-1104
pubmed: 30326503

Auteurs

Huiqing Li (H)

Division of Cardiovascular Sciences (H.L., M.M., C.B., N.D., M.C., G.S.W., D.C.G., X.-z. J. L.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Marissa Miller (M)

Division of Cardiovascular Sciences (H.L., M.M., C.B., N.D., M.C., G.S.W., D.C.G., X.-z. J. L.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Catherine Burke (C)

Division of Cardiovascular Sciences (H.L., M.M., C.B., N.D., M.C., G.S.W., D.C.G., X.-z. J. L.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Narasimhan Danthi (N)

Division of Cardiovascular Sciences (H.L., M.M., C.B., N.D., M.C., G.S.W., D.C.G., X.-z. J. L.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Marc Charette (M)

Division of Cardiovascular Sciences (H.L., M.M., C.B., N.D., M.C., G.S.W., D.C.G., X.-z. J. L.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Weiniu Gan (W)

Division of Lung Diseases (W.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Pankaj Qasba (P)

Division of Blood Diseases and Resources (P.Q.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Gina S Wei (GS)

Division of Cardiovascular Sciences (H.L., M.M., C.B., N.D., M.C., G.S.W., D.C.G., X.-z. J. L.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

David C Goff (DC)

Division of Cardiovascular Sciences (H.L., M.M., C.B., N.D., M.C., G.S.W., D.C.G., X.-z. J. L.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Xiao-Zhong James Luo (XJ)

Division of Cardiovascular Sciences (H.L., M.M., C.B., N.D., M.C., G.S.W., D.C.G., X.-z. J. L.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH